Possibility of new competition concerns New York’s existing medical cannabis companies


By Omar Sacirbey

Medical marijuana businesses in New York are hopeful that recent and proposed changes to the state’s MMJ program will increase patient numbers and boost sales.

But the five existing companies, currently operating below their capacities, worry those gains could be negated by plans to allow newcomers to enter the market.

“Adding new registered organizations will divide up the patients even more. They need to fix the demand side first and then adjust supply,” said Jeremy Unruh, general counsel at PharmaCann, one of the…

CONTINUE READING: Click Here to Continue Reading Article …